or
Bookmark and Share
Hepatitis C antigen--antibody combination assay for the early detection of infection
   
Document Number
US Patent 6723502
Issued Date
April 20, 2004
Link
Inventors
Bahl; Chander (Flemington, NJ)
Map
Abstract
Described herein is an ELISA based assay for the detection of HCV infection. This new assay can detect HCV infection earlier than the currently used assays for the screening of blood for HCV infection by using a combination of HCV antigens and anti-core antibodies to capture HCV.
Tags:
Description:
Amusing 0%
Clever 0%
Complex 0%
Efficient 0%
Historic 0%
Important 0%
Innovative 0%
Interesting 0%
Practical 0%
Simple 0%
Number of Claims:
2
Comments:
no comments yet
Owner
Published
April 20, 2004
Application Number
10/108,610
Filed
March 28, 2002
US Classification
435/5   436/518
Int'l Classification
G01N   33/576   (20060101)  
Parent Case
This application claims the benefit of U.S. provisional application No. 60/279,276 filed Mar. 28, 2001.
USPTO Field of Search
435/5   436/518  
Related Patents
7332269 - HCV core protein sequences - Owned by Ortho-Clinical Diagnostics, Inc. (Rochester, NY)

The present invention describes peptides and recombinant proteins containing Hepatitis C virus core protein sequence in which one or more of the amino acids have been modified or deleted to remove the ability of these proteins to bind to specific anti-HCV murine monoclonal antibodies. The deletions and modifications are designed as to maintain the ability of this protein to be used in immunoassays used for the detection of anti-HCV antibodies in individuals infected with HCV.

Claims
Description
About| FAQs| Terms & Disclaimer| Link to Us| Contact Us